4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-21-014557
Options or other derivatives
- CEO acquired 205,012 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2021-02-23 | Grant or award · Stock Options (Right to Buy) | +161,230 | 161,230 | D | ||
| DAVIS STEPHEN CEO | 2021-02-23 | Grant or award · Restricted Stock Units | +43,782 | 43,782 | D | ||
Loading xslF345X03/doc4.xml…